Compare UBSI & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBSI | TFX |
|---|---|---|
| Founded | 1982 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.1B |
| IPO Year | 1994 | 1994 |
| Metric | UBSI | TFX |
|---|---|---|
| Price | $47.08 | $160.55 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $51.67 | ★ $168.09 |
| AVG Volume (30 Days) | 743.6K | ★ 760.9K |
| Earning Date | 10-22-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.22% | 0.85% |
| EPS Growth | N/A | N/A |
| EPS | 2.77 | ★ 23.58 |
| Revenue | $311,957,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $4.32 | $13.62 |
| Revenue Next Year | $5.54 | $3.78 |
| P/E Ratio | $17.03 | ★ $6.77 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $35.55 | $100.18 |
| 52 Week High | $50.47 | $161.00 |
| Indicator | UBSI | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 44.91 | 80.24 |
| Support Level | $46.28 | $120.85 |
| Resistance Level | $47.77 | N/A |
| Average True Range (ATR) | 0.91 | 4.88 |
| MACD | -0.21 | 0.93 |
| Stochastic Oscillator | 6.38 | 95.40 |
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which offers a full range-of-products and services through various delivery channels. Included among the banking products and services offered are the acceptance of deposits in checking, savings, time, and money market accounts; the making and servicing of personal, credit card, commercial, and floor plan loans; and the making of construction and real estate loans, as well as the origination and sale of residential mortgages in the secondary market. Also offered are trust and brokerage services, safe deposit boxes, and wire transfers.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.